← Back to Search

Geriatric Care Model for Dialysis

N/A
Waitlist Available
Led By Rasheeda K Hall, MD, MBA, MHS, FASN
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Community-dwelling dialysis patients 55 and older
Be older than 18 years old
Must not have
Advanced dementia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4, 8, 12 months
Awards & highlights

Summary

This trial aims to improve dialysis care by getting input from key stakeholders and conducting a small test study to gather important evidence for a larger study in the future. Summary: "This trial aims to

Who is the study for?
This trial is for community-dwelling dialysis patients aged 55 and older, who may have some cognitive impairment. Those with severe cognitive issues can join if they have a caregiver present to assist them during the study.
What is being tested?
The study is testing a new Geriatric Care Model against the usual care given to older adults on dialysis. It's set up as a pilot randomized controlled trial, meaning participants are randomly assigned to one of the two approaches.
What are the potential side effects?
Since this trial compares different care models rather than medications, side effects aren't typical in the same way as drug trials. However, changes in care could lead to variations in comfort or well-being.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 55 or older and receive dialysis while living at home.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have advanced dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4, 8, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in geriatric problem management as measured by survey

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Geriatric Care ModelActive Control1 Intervention
While specifics of the intervention will be finalized after aim 2, the investigators anticipate participants will complete the GOLD and telehealth prioritization visit. Information gathered will guide the research geriatric team's recommendation report to the participants' dialysis care team. The dialysis teams will receive training on how to use the recommendation report and local resources to initiate geriatric problem management.
Group II: Usual CarePlacebo Group2 Interventions
Participants will receive usual dialysis care for 12 months, then they will receive the geriatric care model.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,424 Previous Clinical Trials
3,065,890 Total Patients Enrolled
Rasheeda K Hall, MD, MBA, MHS, FASNPrincipal InvestigatorDuke University
~129 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top